TOPLINE: Loneliness is associated with a higher risk of developing Parkinson disease (PD) across demographic groups and independent of other risk factors, data from nearly 500,000 […]

TOPLINE: Levetiracetam is more effective than is lamotrigine for initial monotherapy in female patients with juvenile myoclonic epilepsy (JME) but not for those with other idiopathic […]

TOPLINE: In patients with fibromyalgia, cognitive behavior therapy (CBT) can reduce pain through its effect on pain-related catastrophizing, which involves intensified cognitive and emotional responses to […]

TOPLINE: Three quarters of patients treated with autologous hematopoietic stem cell transplantation (aHSCT) for relapsing remitting multiple sclerosis (RRMS) were disease free 5 years after therapy […]

TOPLINE: Women with longer reproductive lifespans and prolonged endogenous hormone exposure may be less likely to develop cerebral small vessel disease, regardless of their history of […]

An experimental stem cell therapy for the treatment of mild to moderate amyotrophic lateral sclerosis (ALS) received a resounding rejection today from a US Food and […]

The American Academy of Neurology (AAN) has outlined its vision for optimizing brain health by 2050. The new strategy includes a focus on preventive neurology, accelerating […]

The US Food and Drug Administration (FDA) review has raised concerns about the safety and efficacy of an experimental stem cell therapy for amyotrophic lateral sclerosis […]

Traumatic brain injury (TBI) that occurs in early adulthood is associated with cognitive decline in later life, results from a study of identical twins who served […]